We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HALL
13326
DELISTED
Hallmark Financial Services, Inc.
HALL
$44K ﹤0.01%
1,201
-36
-3% -$1.53K
SPPI
13327
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$44K ﹤0.01%
20,335
-131,339
-87% -$359K
JP
13328
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
$44K ﹤0.01%
+41,832
New +$55.8K
KURIW
13329
DELISTED
Alkuri Global Acquisition Corp Warrant
KURIW
$44K ﹤0.01%
30,985
-124,217
-80% -$185K
ARMP icon
13330
Armata Pharmaceuticals
ARMP
$167M
$43K ﹤0.01%
11,783
+910
+8% +$3.46K
AYTU icon
13331
PUT
AYTU BioPharma
AYTU
$23.9M
$43K ﹤0.01%
745
-670
-47% -$50.3K
EPOW icon
13332
E-Power Inc
EPOW
$16.7M
$43K ﹤0.01%
+18,830
New +$50.2K
OXSQ icon
13333
Oxford Square Capital
OXSQ
$163M
$43K ﹤0.01%
10,583
-8,786
-45% -$39.9K
PXJ icon
13334
CALL
Invesco Oil & Gas Services ETF
PXJ
$65.9M
$43K ﹤0.01%
2,440
-2,040
-46% -$34.2K
DVLT
13335
CALL
Datavault AI
DVLT
$291M
$43K ﹤0.01%
+1
New +$50K
NEPT
13336
PUT
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$43K ﹤0.01%
51
-41
-45% -$43.3K
IMV
13337
DELISTED
IMV Inc. Common Shares
IMV
$43K ﹤0.01%
2,590
+1,136
+78% +$19.6K
SIOX
13338
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$43K ﹤0.01%
19,800
-26,600
-57% -$57.8K
QUMU
13339
PUT
DELISTED
Qumu Corp.
QUMU
$43K ﹤0.01%
17,400
-19,700
-53% -$52.3K
HMCOW
13340
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$43K ﹤0.01%
+40,502
New +$42.8K
ZVO
13341
DELISTED
Zovio Inc. Common Stock
ZVO
$43K ﹤0.01%
17,971
-4,212
-19% -$10.4K
PHAS
13342
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$43K ﹤0.01%
13,907
-26,477
-66% -$88.4K
PBLA
13343
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$43K ﹤0.01%
+1
New +$58.5K
BXRX
13344
CALL
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$43K ﹤0.01%
54
-51
-49% -$44.4K
TLGT
13345
DELISTED
Teligent, Inc
TLGT
$43K ﹤0.01%
108,162
-195,454
-64% -$85.5K
AVX
13346
Avax One Technology Ltd
AVX
$21.7M
0
GTE icon
13347
CALL
Gran Tierra Energy
GTE
$265M
$42K ﹤0.01%
5,650
+220
+4% +$1.33K
HEPA
13348
CALL
DELISTED
Hepion Pharmaceuticals
HEPA
$42K ﹤0.01%
28
-77
-73% -$123K
MRKR icon
13349
PUT
Marker Therapeutics
MRKR
$18.8M
$42K ﹤0.01%
2,470
-2,280
-48% -$46.7K
PRPO icon
13350
PUT
Precipio
PRPO
$38.7M
$42K ﹤0.01%
740
-1,055
-59% -$66.1K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.